Alpha Tau Medical Ltd (DRTS) — Strategic Asset Allocation Index
Alpha Tau Medical Ltd (DRTS) has a Strategic Asset Allocation Index of 15.9% as of June 2023. Strategic assets (PP&E of $14.71 Million plus long-term investments of $-) total $14.71 Million, measured against net assets of $92.56 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Alpha Tau Medical Ltd Strategic Asset Allocation Index (2022–2022)
This chart shows how Alpha Tau Medical Ltd's Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of June 2023, the index stands at 15.9%, representing strategic assets of $14.71 Million against net assets of $92.56 Million USD. Explore Alpha Tau Medical Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Alpha Tau Medical Ltd (2022–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Alpha Tau Medical Ltd from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Alpha Tau Medical Ltd market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 12.6% | $13.28 Million | $13.28 Million | $- | $105.66 Million | — |